CHD5 and cancer: Subsequently, CHD5 has been reported to be mutated, deleted or silenced in a variety of human cancers including glioma, leukemia/lymphoma, melanoma, breast, prostate, ovarian and gastric cancers [5], [6], [7], [8], [9], [10], [11], [12], [13].